I45M (p.Ile45Met) variant of SGCD (Delta-sarcoglycan)
I45M (p.Ile45Met) in SGCD (Delta-sarcoglycan) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes structural context.
I45M (p.Ile45Met) variant details
- p.Ile45Met
- NCI-TCGA Cosmic COSV1005
- cosmic curated COSV10054
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.241
- ESM-1b 0.00
- AlphaMissense 0.36
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available